About J. Michael Gonzalez-Campoy, MD, PhD, FACE

J. Michael Gonzalez-Campoy, MD, PhD, FACE, is medical director and CEO of the Minnesota Center for Obesity, Metabolism, and Endocrinology (MNCOME). He is a recognized national expert on diabetes and obesity and a proponent of adiposopathy as a treatment target.

Dr. Gonzalez-Campoy is clinical assistant professor of medicine at the University of Minnesota. He is board certified in endocrinology, diabetes, and metabolism. He has been a member of the Board of Directors of the American Association of Clinical Endocrinologists (AACE) since 2005 and is a member of the Board of Directors of the American College of Endocrinology (ACE).

Dr. Gonzalez-Campoy received his MD and PhD (PhD in physiology and biophysics) from Mayo Medical School and Mayo Graduate School in Rochester, MN. He completed his residency in internal medicine at the Mayo Graduate School of Medicine. Dr. Gonzalez-Campoy concluded his training with a fellowship in diabetes, endocrinology, and metabolism at the University of Minnesota in Minneapolis, MN.

Dr. Gonzalez-Campoy is the first Hispanic past president of the Minnesota Medical Association and held the designated position for a minority physician at the House of Delegates of the American Medical Association at its inception. In addition, he represents AACE as a member of the Steering Committee for the National Diabetes Education Program.

Dr. Gonzalez-Campoy is dedicated to advancing the care of patients with obesity. He has authored the Power of Prevention website content on obesity, co-authored the AACE clinical practice guidelines on bariatric surgery and obesity, and is working diligently to validate the concept that the adipocyte is an endocrine cell and a treatment target for endocrinologists.